ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 114 filers reported holding ANAPTYSBIO INC in Q1 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,791 | -20.1% | 23,485 | -9.5% | 0.00% | -100.0% |
| Q2 2023 | $527,782 | +14.1% | 25,948 | +22.1% | 0.00% | – |
| Q1 2023 | $462,618 | -23.0% | 21,260 | +9.7% | 0.00% | -100.0% |
| Q4 2022 | $600,586 | +70.1% | 19,380 | +40.1% | 0.00% | – |
| Q3 2022 | $353,000 | +26.5% | 13,831 | +0.7% | 0.00% | – |
| Q2 2022 | $279,000 | -21.6% | 13,735 | -4.7% | 0.00% | – |
| Q1 2022 | $356,000 | -30.3% | 14,415 | -2.0% | 0.00% | – |
| Q4 2021 | $511,000 | +37.7% | 14,703 | +7.7% | 0.00% | – |
| Q3 2021 | $371,000 | +33.9% | 13,649 | +28.1% | 0.00% | – |
| Q2 2021 | $277,000 | -41.3% | 10,658 | -51.3% | 0.00% | – |
| Q1 2021 | $472,000 | -46.5% | 21,896 | -46.7% | 0.00% | – |
| Q4 2020 | $882,000 | +31.1% | 41,090 | -9.9% | 0.00% | – |
| Q3 2020 | $673,000 | -59.8% | 45,629 | -39.1% | 0.00% | -100.0% |
| Q2 2020 | $1,675,000 | +87.4% | 74,966 | +18.5% | 0.00% | 0.0% |
| Q1 2020 | $894,000 | -18.0% | 63,245 | -5.7% | 0.00% | 0.0% |
| Q4 2019 | $1,090,000 | +45.1% | 67,091 | +212.7% | 0.00% | 0.0% |
| Q3 2019 | $751,000 | -63.0% | 21,453 | -40.4% | 0.00% | -50.0% |
| Q2 2019 | $2,032,000 | +85.7% | 36,012 | +140.6% | 0.00% | +100.0% |
| Q1 2019 | $1,094,000 | +24.6% | 14,968 | +8.8% | 0.00% | 0.0% |
| Q4 2018 | $878,000 | +29.1% | 13,761 | +101.9% | 0.00% | 0.0% |
| Q3 2018 | $680,000 | -19.2% | 6,816 | -42.4% | 0.00% | 0.0% |
| Q2 2018 | $842,000 | -38.2% | 11,842 | -9.5% | 0.00% | 0.0% |
| Q1 2018 | $1,362,000 | -17.4% | 13,085 | -20.0% | 0.00% | 0.0% |
| Q4 2017 | $1,648,000 | +408.6% | 16,363 | +76.1% | 0.00% | – |
| Q3 2017 | $324,000 | – | 9,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |